Technology Focus: Antibodies - End of the Boom?
By Business Review Editor
Pharma Deals Review: Vol 2007 Issue 79 (Table of Contents)
Published: 1 Jan-2007
DOI: 10.3833/pdr.v2007.i79.401 ISSN: 1756-7874
Section: Features
Fulltext:
Abstract
The origins of, and developments in, monoclonal antibody (MAb) technology are outlined, with discussion of past and possible future deal making trends...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS